Irifrin eye drops 5ml 2,5% Phenylephrin Ирифрин

Irifrin (phenylephrine)

Irifrin contains the active ingredient phenylephrine, alpha-adrenergic agonist mydriatic.

Irifrin Indications

– Iridocyclitis, anterior uveitis (to treat and prevent the rear of adhesions and reduction of exudation from the iris of the eye).
– Diagnostic pupil dilation with ophthalmoscopy and other diagnostic procedures necessary to determine the status of the posterior eye segment).
– Conduct a provocative test in patients with a narrow profile of the anterior chamber angle and suspected angle-closure glaucoma.
– Differential diagnosis of the type of injection of the eyeball.
– Pupil dilation when performing laser interventions in the fundus and vitreo-retinal surgery.
– Syndrome of “red eye” (to reduce redness and irritation of the membranes of the eye).
– Complex therapy of spasm of accommodation in children of school age.
– Treatment and prevention of asthenopia.

Contraindications

─ Hypersensitivity to any component of the drug.

─ Angle-closure glaucoma.

─ Significant disorders of the cardiovascular system (heart disease, hypertension, aneurysm, tachycardia), especially for elderly patients.

─ Insulin-dependent diabetes mellitus.

─ Thyrotoxicosis.

─ Hyperthyroidism.Method of application and doses.

Dosage & Administration

When ophthalmoscopy it is necessary apply disposable stelazy 2.5% solution. As a rule, for achievement of mydriasis enough the introduction of 1 drop of 2.5% solution of the drug in the conjunctival sac.

Maximal mydriasis is achieved after 15-30 minutes and is maintained at a sufficient level within 1-3 hours. If necessary, the maintenance of mydriasis for a long time over 1 h are possible with repeated instillation.

Browse more eye treatments available with international delivery.